Awakn Acquires Proprietary Next Generation MDMA and Ketamine Data from Prof. David Nutt

CANNANNEW REPORT

Prof. Nutt appointed Head of Research to Lead Awakn’s Next-Gen Psychedelic Molecule Development Awakn Life Sciences announces the acquisition of… Read More…..

Excerpt only …
READ MORE BELOW
Source : Awakn Acquires Proprietary Next Generation MDMA and Ketamine Data from Prof. David Nutt

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.